Abiopharma

🔍 DISCOVERY CAPITAL MANAGEMENT, LLC / CT (Executive)

Company: Ramaco Resources, Inc. (METC)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 200,000 shares of Class A Common Stock, $0.01 par value at $14.79 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,311,360.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The securities are held in the account of Discovery Global Opportunity Master Fund, Ltd. (the "Fund") and may be deemed to be beneficially owned by Discovery Capital Management, LLC ("Discovery"), as the investment manager of the Fund, and Robert K. Citrone, as the managing member of Discovery.
• REMARKS: Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.